Brief: Stayble Therapeutics Says Positive Results From Company's Clinical Phase 1B Study In Lumbar Disc Herniation

Stayble Therapeutics AB

13/11/2024 18:02

Nov 13 (Reuters) - Stayble Therapeutics AB  STABL.ST :
    * POSITIVE RESULTS FROM COMPANY'S CLINICAL PHASE 1B STUDY IN
LUMBAR DISC HERNIATION (LDH)
    * STUDY MET ITS PRIMARY SAFETY AND TOLERABILITY ENDPOINT

Source text:  ID:nWkr9CYLC5 
Further company coverage:  STABL.ST 

 ((Reuters.Briefs@thomsonreuters.com;))